Chief of Surgical Oncology
The Ohio State University
Columbus, OH, United States
Allan Tsung, MD is a Professor and Chief of the Division of Surgical Oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and the Ohio State University College of Medicine.
Dr. Tsung’s clinical interests center on evaluating and managing patients with liver, bile duct and pancreas cancers, with expertise in laparoscopic and robotic surgery. He has a research laboratory focused on the hypothesis that inflammatory responses can alter the local tumor microenvironment, leading to cancer progression via tumor cell survival, expansion and metastases. His research also evaluates the contribution of molecular markers in the diagnosis and clinical management of patients with hepatobiliary and pancreas cancers and projects focusing on improving the access, delivery and quality of surgical oncology care.
Dr. Tsung’s work has generated 300+ published peer-reviewed manuscripts in leading scientific journals and culminated in multiple principal investigator NIH R01 grants and many society and institutional grants. His long-term goal is to continue bringing bench side research breakthroughs to bedside clinical therapies. As an advocate for medical students, general surgery residents and surgical oncology fellows, Dr. Tsung is the program director for the complex general surgical oncology fellowship at Ohio state and previously served as Vice Chair of Research for the Department of Surgery at University of Pittsburgh Medical Center. He is past president of the Society of University Surgeons and current president of the Society of Asian Academic Surgeons. He participates in leadership roles in several other important academic surgical organizations, such as the Society of Surgical Oncology, the Americas Hepato-Pancreato-Biliary Association and the American Association for the Study of Liver Diseases.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Wednesday, March 9, 2022
7:00 AM – 4:45 PM CST